- Home
- HTH vs DYN Comparison
HTH vs DYN Comparison
Compare HTH & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTH
- DYN
- Stock Information
- Founded
- HTH 1998
- DYN 1984
- Country
- HTH United States
- DYN United States
- Employees
- HTH N/A
- DYN N/A
- Industry
- HTH Major Banks
- DYN Medicinal Chemicals and Botanical Products
- Sector
- HTH Finance
- DYN Health Care
- Exchange
- HTH Nasdaq
- DYN Nasdaq
- Market Cap
- HTH 2.1B
- DYN 1.9B
- IPO Year
- HTH 2004
- DYN 2020
- Fundamental
- Price
- HTH $32.73
- DYN $13.91
- Analyst Decision
- HTH Hold
- DYN Strong Buy
- Analyst Count
- HTH 1
- DYN 14
- Target Price
- HTH $32.00
- DYN $34.93
- AVG Volume (30 Days)
- HTH 319.1K
- DYN 2.5M
- Earning Date
- HTH 10-23-2025
- DYN 11-11-2025
- Dividend Yield
- HTH 2.20%
- DYN N/A
- EPS Growth
- HTH 27.10
- DYN N/A
- EPS
- HTH 2.22
- DYN N/A
- Revenue
- HTH $1,233,449,000.00
- DYN N/A
- Revenue This Year
- HTH N/A
- DYN N/A
- Revenue Next Year
- HTH $0.66
- DYN N/A
- P/E Ratio
- HTH $14.76
- DYN N/A
- Revenue Growth
- HTH 4.92
- DYN N/A
- 52 Week Low
- HTH $26.67
- DYN $6.36
- 52 Week High
- HTH $36.14
- DYN $35.90
- Technical
- Relative Strength Index (RSI)
- HTH 37.91
- DYN 59.63
- Support Level
- HTH $32.61
- DYN $12.43
- Resistance Level
- HTH $33.62
- DYN $13.07
- Average True Range (ATR)
- HTH 0.66
- DYN 0.78
- MACD
- HTH -0.22
- DYN -0.01
- Stochastic Oscillator
- HTH 2.96
- DYN 88.51
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.